Key Facts
EXPERT aims at developing a new off-the-shelf delivery system for RNA-based nanomedicines to treat cancer and cardiovascular disease. In the long term, the platform technology could be used for improving diagnostic and therapeutic options for patients with several other diseases.
Duration
66 months
Funding
14.9 Mio €
Partners
11
Countries involved
The Netherlands
Sweden
Belgium
Norway
Ireland
Hungary
Israel
France
Spain
Germany